Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43174 |
| MITOMYCIN FOR INJECTION | 20MG | POWDER FOR SOLUTION | Resolved | 2018-05-11 | 2018-07-30 | 49124 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50023 |
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50026 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50029 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2018-06-15 | 2019-05-28 | 52485 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-06-15 | 2018-11-08 | 52488 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2018-06-22 | 2018-10-11 | 52823 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2018-08-21 | 2018-11-08 | 58634 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2018-08-31 | 2018-10-20 | 59704 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-31 | 2019-04-11 | 59708 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-31 | 2019-04-11 | 59711 |
| TEVA-AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60068 |
| TEVA-AMPHETAMINE XR | 5MG 5MG 5MG 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60075 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2018-09-06 | 2019-04-11 | 60121 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2018-09-06 | 2019-04-11 | 60124 |
| ACT PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2018-09-06 | 2019-04-11 | 60129 |
| TEVA-AMPHETAMINE XR | 6.25MG 6.25MG 6.25MG 6.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61330 |
| TEVA-AMPHETAMINE XR | 7.5MG 7.5MG 7.5MG 7.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61333 |
| TEVA-AMPHETAMINE XR | 1.25MG 1.25MG 1.25MG 1.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61336 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |